Neuromed Pharmaceuticals
About:
Neuromed Pharmaceuticals, Ltd., a biopharmaceutical company, develops, produces, markets, and sells pain therapies.
Website: http://www.neuromed.com/
Top Investors: BDC Venture Capital, RBC Capital, MPM Capital, Business Development Bank of Canada, RBC Venture Partners
Description:
Neuromed Pharmaceuticals is focused on the development, production, and marketing of pain therapies in Canada and the United States. Neuromed Pharmaceuticals was acquired by Zalicus in December 2009. Neuromed Pharmaceuticals was founded in 1998 and is based in Vancouver, Canada.
Total Funding Amount:
$136M
Headquarters Location:
Vancouver, British Columbia, Canada
Founded Date:
1998-01-01
Founders:
Number of Employees:
11-50
Last Funding Date:
2007-08-21
IPO Status:
Private
Industries:
© 2025 bioDAO.ai